Long-term follow-up of achalasia patients treated with botulinum toxin

V. D'Onofrio, P. Miletto, G. Leandro, G. Iaquinto

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Aims. To evaluate long-term efficacy of intrasphincteric injection of botulinum toxin in untreated achalasia patients; to analyse whether age can be a predictor of response; and to verify whether any objective measurements correlate with symptom relief. Materials and Methods. A total of 37 patients (mean age 61.4±17.5 years) were enrolled, all of whom injected endoscopically with 100 U of botulinum toxin. Symptom score, oesophageal manometry and oesophageal radionuclide emptying were assessed prior to treatment and 4 weeks, 3 months and 1 year after botulinum toxin. In the case of failure or relapse (symptom score >2), treatment was repeated. Results. All but 6 patients (83.7%) were in clinical remission one month after botulinum toxin. At 12 months, mean symptom score was 0.9±0.5 (p

Original languageEnglish
Pages (from-to)105-110
Number of pages6
JournalDigestive and Liver Disease
Volume34
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Esophageal Achalasia
Botulinum Toxins
Manometry
Radioisotopes
Recurrence
Injections
Therapeutics

Keywords

  • Achalasia
  • Botulinum toxin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Long-term follow-up of achalasia patients treated with botulinum toxin. / D'Onofrio, V.; Miletto, P.; Leandro, G.; Iaquinto, G.

In: Digestive and Liver Disease, Vol. 34, No. 2, 2002, p. 105-110.

Research output: Contribution to journalArticle

D'Onofrio, V. ; Miletto, P. ; Leandro, G. ; Iaquinto, G. / Long-term follow-up of achalasia patients treated with botulinum toxin. In: Digestive and Liver Disease. 2002 ; Vol. 34, No. 2. pp. 105-110.
@article{92f5c12c48d74b81b9529d041d57783e,
title = "Long-term follow-up of achalasia patients treated with botulinum toxin",
abstract = "Aims. To evaluate long-term efficacy of intrasphincteric injection of botulinum toxin in untreated achalasia patients; to analyse whether age can be a predictor of response; and to verify whether any objective measurements correlate with symptom relief. Materials and Methods. A total of 37 patients (mean age 61.4±17.5 years) were enrolled, all of whom injected endoscopically with 100 U of botulinum toxin. Symptom score, oesophageal manometry and oesophageal radionuclide emptying were assessed prior to treatment and 4 weeks, 3 months and 1 year after botulinum toxin. In the case of failure or relapse (symptom score >2), treatment was repeated. Results. All but 6 patients (83.7{\%}) were in clinical remission one month after botulinum toxin. At 12 months, mean symptom score was 0.9±0.5 (p",
keywords = "Achalasia, Botulinum toxin",
author = "V. D'Onofrio and P. Miletto and G. Leandro and G. Iaquinto",
year = "2002",
doi = "10.1016/S1590-8658(02)80238-9",
language = "English",
volume = "34",
pages = "105--110",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Long-term follow-up of achalasia patients treated with botulinum toxin

AU - D'Onofrio, V.

AU - Miletto, P.

AU - Leandro, G.

AU - Iaquinto, G.

PY - 2002

Y1 - 2002

N2 - Aims. To evaluate long-term efficacy of intrasphincteric injection of botulinum toxin in untreated achalasia patients; to analyse whether age can be a predictor of response; and to verify whether any objective measurements correlate with symptom relief. Materials and Methods. A total of 37 patients (mean age 61.4±17.5 years) were enrolled, all of whom injected endoscopically with 100 U of botulinum toxin. Symptom score, oesophageal manometry and oesophageal radionuclide emptying were assessed prior to treatment and 4 weeks, 3 months and 1 year after botulinum toxin. In the case of failure or relapse (symptom score >2), treatment was repeated. Results. All but 6 patients (83.7%) were in clinical remission one month after botulinum toxin. At 12 months, mean symptom score was 0.9±0.5 (p

AB - Aims. To evaluate long-term efficacy of intrasphincteric injection of botulinum toxin in untreated achalasia patients; to analyse whether age can be a predictor of response; and to verify whether any objective measurements correlate with symptom relief. Materials and Methods. A total of 37 patients (mean age 61.4±17.5 years) were enrolled, all of whom injected endoscopically with 100 U of botulinum toxin. Symptom score, oesophageal manometry and oesophageal radionuclide emptying were assessed prior to treatment and 4 weeks, 3 months and 1 year after botulinum toxin. In the case of failure or relapse (symptom score >2), treatment was repeated. Results. All but 6 patients (83.7%) were in clinical remission one month after botulinum toxin. At 12 months, mean symptom score was 0.9±0.5 (p

KW - Achalasia

KW - Botulinum toxin

UR - http://www.scopus.com/inward/record.url?scp=0036189840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036189840&partnerID=8YFLogxK

U2 - 10.1016/S1590-8658(02)80238-9

DO - 10.1016/S1590-8658(02)80238-9

M3 - Article

VL - 34

SP - 105

EP - 110

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 2

ER -